Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Delivery Mode
6.1 Cloud-based Clinical Trial Management System
6.2 On-Premise Clinical Trial Management System
6.3 Web-based Clinical Trial Management System
Chapter 7 Market Segmentation, By Components
7.1 Services
7.2 Hardware
7.3 Software
Chapter 8 Market Segmentation, By End-User
8.1 Healthcare Providers
8.1.1 Cancer Centres
8.1.2 Academic Medical Centres
8.1.3 Clinics
8.1.4 Research Hospitals
8.2 Pharmaceuticals & Biotechnology Companies
Chapter 9 Market Segmentation, By Type
9.1 Licensed Enterprise based Clinical Trial Management System
9.2 Site based Clinical Trial Management System
Chapter 10 Market Segmentation, By Applications
10.1 Document Management Solutions
10.2 Data Management Solutions
10.3 Site Management Solutions
10.4 Patient Management Solutions
Chapter 11 Market Segmentation, By Geography
11.1 North America
11.1.1 Introduction
11.1.2 United States
11.1.3 Canada
11.1.4 Mexico
11.1.5 Others
11.2 Europe
11.2.1 Introduction
11.2.2 U.K
11.2.3 Spain
11.2.4 Italy
11.2.5 France
11.2.6 Russia
11.2.7 Others
11.3 Asia-Pacific
11.3.1 Introduction
11.3.2 China
11.3.3 India
11.3.4 Japan
11.3.5 Australia
11.3.6 Others
11.4 South America
11.4.1 Introduction
11.4.2 Brazil
11.4.3 Argentina
11.4.4 Others
11.5 The Middle East & Africa
11.5.1 Introduction
11.5.2 South Africa
11.5.3 Others
Chapter 12 Competitive Landscape
12.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
12.2 Market Share Analysis
12.3 Strategies Adopted By Top Companies
Chapter 13 Company Profiles
13.1. Omnicomm Systems
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Benchmarking
13.1.4. Strategic Initiative
13.2. DSG
13.3. Parexel
13.4. Bio-Optronics
13.5. Medidata
13.6. Forte Research Systems
13.7. BioClinica
13.8. Sparta Systems
13.9. Merge Healthcare
13.10. Oracle
13.11. eClinForce Inc.
13.12. VEEVA Systems Inc.
13.13. DATATRAK International Inc.
13.14. MedNet Solutions
13.15. Aris Global, LLC
Chapter 14 Market Estimates and Forecast
14.1 Market Estimates and Forecast 2018-2024(USD Million)
14.1.1 Market Estimation and Forecast by Delivery Mode 2018-2024 (USD Million)
14.1.2 Market Estimation and Forecast by Components 2018-2024 (USD Million)
14.1.3 Market Estimation and Forecast by End User 2018-2024 (USD Million)
14.1.4 Market Estimation and Forecast by Type 2018-2024 (USD Million)
14.1.5 Market Estimation and Forecast by Applications 2018-2024 (USD Million)
14.1.6 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 15 Market Insights
15.1 Insights of Industry Experts
15.2 Analyst Opinion (Market Understanding)
15.3 Investment Opportunities
Chapter 16 Appendix
16.1 List of Tables
16.2 List of Figures
